Key Takeaways
- AstraZeneca (AZN) received FDA approval for Truqap (capivasertib) as the first targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer, reducing the risk of disease progression or death by 19%.
- The UK Government confirmed a January 1, 2027 end date for imports of Russian diesel and jet fuel refined in third countries, closing a major "loophole" in its sanctions regime.
- The IMF reached a staff-level agreement with Ukraine on the first review of its $8.1 billion loan program, clearing the path for a $690 million disbursement pending board approval.
- Ukraine met all quantitative performance criteria for the review period, though it missed one structural benchmark, requiring a revised reform timeline to maintain program momentum.
AstraZeneca Secures Landmark FDA Approval for Truqap
AstraZeneca (AZN) announced on Friday that the U.S. Food and Drug Administration (FDA) has approved Truqap (capivasertib) in combination with abiraterone and prednisone. This regulatory milestone establishes Truqap as the first and only targeted therapy specifically for adult patients with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC).
The approval is based on the Phase III CAPItello-281 trial, which demonstrated that the combination therapy achieved a median radiographic progression-free survival (rPFS) of 33.2 months, compared to 25.7 months for the control group. PTEN deficiency, which occurs in approximately 25% of mHSPC cases, is typically associated with a poorer prognosis and faster disease progression.
UK Sets Final Deadline for Russian Refined Fuel Imports
The UK Government has officially set January 1, 2027, as the expiration date for the temporary license allowing the import of Russian-origin diesel and jet fuel processed in third countries. This move follows a new ban introduced on May 20, 2026, which initially included exemptions to maintain market stability and protect domestic supply chains.
The Department for Business and Trade stated the timeline is designed to maximize pressure on the Russian economy while ensuring a smooth transition for UK businesses. Officials will continue to review the license every two weeks, with the intention to lift it sooner if market conditions allow. Energy analysts suggest the move aims to eliminate the "refining loophole" that has allowed Russian crude to enter Western markets via third-party refineries.
IMF and Ukraine Reach Agreement on $8.1 Billion Loan Review
The International Monetary Fund (IMF) and Ukrainian authorities have reached a staff-level agreement on the first review of the country’s $8.1 billion Extended Fund Facility (EFF). Upon approval by the IMF Executive Board, expected next month, Ukraine will gain access to approximately $690 million (SDR 503 million), bringing total disbursements under the current program to $2.2 billion.
The IMF noted that Ukraine met all end-March quantitative performance criteria and indicative targets despite the ongoing conflict. However, because one structural benchmark was missed and two others were delayed, the agreement includes a revised timeline for reforms and additional policy commitments. The funds are earmarked to bolster macro-financial stability and support priority government expenditures as the country manages a total financing gap estimated at $136.5 billion through 2029.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.